Skip to main content

Peer Review reports

From: LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma

Original Submission
24 Jul 2018 Submitted Original manuscript
7 Sep 2018 Author responded Author comments - Longzhen Piao
Resubmission - Version 2
7 Sep 2018 Submitted Manuscript version 2
11 Feb 2019 Reviewed Reviewer Report - Shengxiang Ren
28 Feb 2019 Reviewed Reviewer Report - Reviewer 2
30 Mar 2019 Author responded Author comments - Longzhen Piao
Resubmission - Version 3
30 Mar 2019 Submitted Manuscript version 3
8 May 2019 Reviewed Reviewer Report - Reviewer 2
3 Jun 2019 Reviewed Reviewer Report - Reviewer 3
25 Jun 2019 Author responded Author comments - Longzhen Piao
Resubmission - Version 4
25 Jun 2019 Submitted Manuscript version 4
10 Jul 2019 Reviewed Reviewer Report - Reviewer 3
30 Jul 2019 Reviewed Reviewer Report - Reviewer 2
26 Aug 2019 Author responded Author comments - Longzhen Piao
Resubmission - Version 5
26 Aug 2019 Submitted Manuscript version 5
29 Aug 2019 Author responded Author comments - Longzhen Piao
Resubmission - Version 6
29 Aug 2019 Submitted Manuscript version 6
Publishing
3 Sep 2019 Editorially accepted
9 Sep 2019 Article published 10.1186/s12885-019-6128-9

You can find further information about peer review here.

Back to article page